LRMDA: Using Logistic Regression and Random Walk with Restart for MiRNA-Disease Association Prediction
暂无分享,去创建一个
Zhu-Hong You | Yang Wang | Yan Zhao | Xin Ge | Ru Nie | Zhengwei Li | Yan Zhao | Zhuhong You | Zhengwei Li | Ru Nie | Yang Wang | Xin-Shun Ge
[1] Xing Chen,et al. In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences , 2017, Scientific Reports.
[2] Yadong Wang,et al. miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..
[3] Q. Wei,et al. Genetic variants in miR-196a2 and miR-499 are associated with susceptibility to esophageal squamous cell carcinoma in Chinese Han population , 2016, Tumor Biology.
[4] Xing Chen,et al. PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..
[5] Xia Li,et al. Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.
[6] Yang Li,et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..
[7] Xing Chen,et al. LMTRDA: Using logistic model tree to predict MiRNA-disease associations by fusing multi-source information of sequences and similarities , 2019, PLoS Comput. Biol..
[8] Zhaoli Chen,et al. microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin* , 2010, The Journal of Biological Chemistry.
[9] Xing Chen,et al. MCMDA: Matrix completion for MiRNA-disease association prediction , 2017, Oncotarget.
[10] Zhu-Hong You,et al. A novel computational model based on super-disease and miRNA for potential miRNA-disease association prediction. , 2017, Molecular bioSystems.
[11] Xing Chen,et al. EGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association prediction , 2018, Cell Death & Disease.
[12] Mario Acunzo,et al. Downregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic Leukemia. , 2016, Clinical chemistry.
[13] Ana Kozomara,et al. miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..
[14] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[15] E. Miska,et al. How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.
[16] Ana Kozomara,et al. miRBase: from microRNA sequences to function , 2018, Nucleic Acids Res..
[17] Zhu-Hong You,et al. PRMDA: personalized recommendation-based MiRNA-disease association prediction , 2017, Oncotarget.
[18] Lei Wang,et al. BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..
[19] Xing Chen,et al. LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association prediction , 2017, PLoS Comput. Biol..
[20] M. Byrom,et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.
[21] Yadong Wang,et al. Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.
[22] Ujjwal Maulik,et al. Development of the human cancer microRNA network , 2010 .
[23] Changning Liu,et al. dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.
[24] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[25] Dong Wang,et al. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..
[26] Xiuwen Yu,et al. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer. , 2015, International journal of clinical and experimental pathology.
[27] H. Qiu,et al. Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2 , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[28] Jian Zhang,et al. Random Walk Based Global Feature for Disease Gene Identification , 2016, CCPR.
[29] Xi Chen,et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. , 2010, Clinical chemistry.
[30] Qionghai Dai,et al. WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.
[31] Xing Chen,et al. Identification of self-interacting proteins by exploring evolutionary information embedded in PSI-BLAST-constructed position specific scoring matrix , 2016, Oncotarget.
[32] Yadong Wang,et al. Predicting human microRNA-disease associations based on support vector machine , 2013, Int. J. Data Min. Bioinform..
[33] Xing Chen,et al. DRMDA: deep representations‐based miRNA–disease association prediction , 2017, Journal of cellular and molecular medicine.
[34] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[35] Yufei Huang,et al. Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.
[36] Zhu-Hong You,et al. EPMDA: an expression profile-based computational model for microRNA-dsease association prediction. , 2017, Oncotarget.
[37] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[38] Xing Chen,et al. Accurate prediction of protein-protein interactions by integrating potential evolutionary information embedded in PSSM profile and discriminative vector machine classifier , 2017, Oncotarget.
[39] Zhu-Hong You,et al. A heterogeneous label propagation approach to explore the potential associations between miRNA and disease , 2018, Journal of Translational Medicine.
[40] Xantha Karp,et al. Encountering MicroRNAs in Cell Fate Signaling , 2005, Science.